Figures & data
Figure 1 Schematic overview of the algorithm.
Notes: aCystectomy or >15 fractions of radiotherapy. bNinety days after cystectomy and 180 days after the last fraction of radiotherapy.
![Figure 1 Schematic overview of the algorithm.Notes: aCystectomy or >15 fractions of radiotherapy. bNinety days after cystectomy and 180 days after the last fraction of radiotherapy.](/cms/asset/784b2ff8-9932-4a00-9815-8a253a57b13b/dcle_a_177305_f0001_c.jpg)
Figure 2 Flowchart of study population.
![Figure 2 Flowchart of study population.](/cms/asset/6829f935-f9b1-4769-9456-0be6bef1664d/dcle_a_177305_f0002_b.jpg)
Table 1 Characteristics of included patients stratified on cancer recurrence status in the DaBlaCa-data (n=187)
Table 2 Concordance of bladder cancer recurrence identified by the gold standard and the algorithm
Table 3 Performance of the algorithm for bladder cancer recurrenceTable Footnotea
Table S1 Agreement between the date of recurrence of bladder cancer identified by the algorithm and the gold standard